SCHEDULE OF LOSS ON DECONSOLIDATION (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Pf Medical | ||
| Note receivable consideration received | $ 47,000 | |
| Carrying amount of non-controlling interest | 902,000 | |
| Carrying amount of accumulated other comprehensive loss | 148,000 | |
| Net liabilities | (35,000) | |
| Transaction costs | 94,000 | |
| Loss on deconsolidation of subsidiary | $ (1,062,000) | |
| X | ||||||||||
- Definition Carrying amount of accumulated other comprehensive loss. No definition available.
|
| X | ||||||||||
- Definition Carrying amount of noncontrolling interest. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Net liabilities. No definition available.
|
| X | ||||||||||
- Definition Note receivable consideration received. No definition available.
|
| X | ||||||||||
- Definition Transaction costs. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|